Overview
Kevin Oeffinger is a primary care provider, practicing in Family Medicine in New York, New York. Dr. Oeffinger is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Wilms Tumor, Cardiomyopathy Due to Anthracyclines, Hodgkin Lymphoma, Splenectomy, and Heart Transplant. Dr. Oeffinger is currently accepting new patients.
His clinical research consists of co-authoring 339 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 15 articles in the study of Acute Lymphoblastic Leukemia (ALL).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- POS
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Vivian Li-Hirashiki is a primary care provider, practicing in Family Medicine in New York, New York. Dr. Li-Hirashiki is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Hepatitis B, Jaundice, Aphthous Stomatitis, and Sutton Disease 2.
Theodore Fried Burford Welch And David Hauer Md, PC
Manuel Rosales is a primary care provider, practicing in Family Medicine and General Practice in Lake Ronkonkoma, New York. Dr. Rosales is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Hypertension, Acute Myeloid Leukemia (AML), Leukemia, and High Cholesterol.
Rutgers Health-Pcc Monument Square
Alisa Reznikov is a primary care provider, practicing in Family Medicine and Geriatrics in New Brunswick, New Jersey. Dr. Reznikov is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Smoldering Multiple Myeloma, Multiple Myeloma, Thrombocytopenia, Bone Marrow Aspiration, and Colonoscopy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Breast CancerDr. Oeffinger isDistinguished. Learn about Breast Cancer.
- Cardiomyopathy Due to AnthracyclinesDr. Oeffinger isDistinguished. Learn about Cardiomyopathy Due to Anthracyclines.
- Hodgkin LymphomaDr. Oeffinger isDistinguished. Learn about Hodgkin Lymphoma.
- Wilms TumorDr. Oeffinger isDistinguished. Learn about Wilms Tumor.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Oeffinger isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Anal CancerDr. Oeffinger isAdvanced. Learn about Anal Cancer.
- CardiomyopathyDr. Oeffinger isAdvanced. Learn about Cardiomyopathy.
- Heart FailureDr. Oeffinger isAdvanced. Learn about Heart Failure.
- LeukemiaDr. Oeffinger isAdvanced. Learn about Leukemia.
- NeuroblastomaDr. Oeffinger isAdvanced. Learn about Neuroblastoma.
- Experienced
- Absence SeizureDr. Oeffinger isExperienced. Learn about Absence Seizure.
- Acute Myeloid Leukemia (AML)Dr. Oeffinger isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Acute PainDr. Oeffinger isExperienced. Learn about Acute Pain.
- Childhood Acute Myeloid LeukemiaDr. Oeffinger isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Chronic PainDr. Oeffinger isExperienced. Learn about Chronic Pain.
- Colorectal CancerDr. Oeffinger isExperienced. Learn about Colorectal Cancer.